-
1
-
-
0036899028
-
Chronic obstructive pulmonary disease. 5: Systemic effects of COPD
-
DOI 10.1136/thorax.57.12.1067
-
Wouters EFM. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax 2002;55:1067-1070. (Pubitemid 35440768)
-
(2002)
Thorax
, vol.57
, Issue.12
, pp. 1067-1070
-
-
Wouters, E.F.M.1
-
2
-
-
43449101586
-
Comorbidities in chronic obstructive pulmonary disease
-
DOI 10.1513/pats.200709-148ET
-
Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:549-555. (Pubitemid 351669185)
-
(2008)
Proceedings of the American Thoracic Society
, vol.5
, Issue.4
, pp. 549-555
-
-
Chatila, W.M.1
Thomashow, B.M.2
Minai, O.A.3
Criner, G.J.4
Make, B.J.5
-
3
-
-
66749141807
-
Systemic manifestations and comorbidities of COPD
-
Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-1185.
-
(2009)
Eur Respir J
, vol.33
, pp. 1165-1185
-
-
Barnes, P.J.1
Celli, B.R.2
-
4
-
-
0036839767
-
Local and systemic inflammation in patients with chronic obstructive pulmonary disease: Soluble tumor necrosis factor receptors are increased in sputum
-
DOI 10.1164/rccm.2202023
-
Vernooy JH, Küçkaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, Wouters EF. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002;166:1218-1224. (Pubitemid 35222599)
-
(2002)
American Journal of Respiratory and Critical Care Medicine
, vol.166
, Issue.9
, pp. 1218-1224
-
-
Vernooy, J.H.1
Kucukaycan, M.2
Jacobs, J.A.3
Chavannes, N.H.4
Buurman, W.A.5
Dentener, M.A.6
Wouters, E.F.7
-
5
-
-
77956686967
-
Sputum neutrophils as a biomarker in COPD: Findings from the ECLIPSE study
-
Singh D, Edwards L, Tal-Singer R, Rennard S. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res 2010;15;11:77.
-
(2010)
Respir Res
, vol.15
, Issue.11
, pp. 77
-
-
Singh, D.1
Edwards, L.2
Tal-Singer, R.3
Rennard, S.4
-
7
-
-
42949160618
-
Possible mechanisms underlying the development of cachexia in COPD
-
Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2007;31:492-501.
-
(2007)
Eur Respir J
, vol.31
, pp. 492-501
-
-
Wagner, P.D.1
-
8
-
-
24944473849
-
Treatment of cachexia with ghrelin in patients with COPD
-
DOI 10.1378/chest.128.3.1187
-
Nagaya N, Itoh T, Murakami S, Oya H, Uematsu M, Miyatake K, Kangawa K. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005;128:1187-1193. (Pubitemid 41324394)
-
(2005)
Chest
, vol.128
, Issue.3
, pp. 1187-1193
-
-
Nagaya, N.1
Itoh, T.2
Murakami, S.3
Oya, H.4
Uematsu, M.5
Miyatake, K.6
Kangawa, K.7
-
9
-
-
57849102724
-
Anabolic steroids in COPD: A review and preliminary results of a randomized trial
-
Sharma S, Arneja A, McLean L, Duerksen D, Leslie W, Sciberras D, Lertzman M. Anabolic steroids in COPD: a review and preliminary results of a randomized trial. Chron Respir Dis 2008;5:169-176.
-
(2008)
Chron Respir Dis
, vol.5
, pp. 169-176
-
-
Sharma, S.1
Arneja, A.2
McLean, L.3
Duerksen, D.4
Leslie, W.5
Sciberras, D.6
Lertzman, M.7
-
10
-
-
73449124097
-
Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: A randomised controlled trial
-
van Wetering CR, Hoogendoorn M, Mol SJ, Rutten-van Mölken MP, Schols AM. Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax 2010;65:7-13.
-
(2010)
Thorax
, vol.65
, pp. 7-13
-
-
Van Wetering, C.R.1
Hoogendoorn, M.2
Mol, S.J.3
Rutten-van Mölken, M.P.4
Schols, A.M.5
-
11
-
-
84855656470
-
Clinical outcome of nutritional intervention integrated in an INTERdisciplinary COMmunity-based COPD lifestyle program (INTERCOM) in moderate COPD
-
Presented at the
-
van Wetering C, Hoogendoorn M, Geraerts-Keeris G, Broekhuizen R, Rutten-van Mölken M, Schols A. Clinical outcome of nutritional intervention integrated in an INTERdisciplinary COMmunity-based COPD lifestyle program (INTERCOM) in moderate COPD. Presented at the European Respiratory Society Meeting October 16, 2008, Berlin, Germany. P4109
-
European Respiratory Society Meeting October 16, 2008, Berlin, Germany
-
-
Van Wetering, C.1
Hoogendoorn, M.2
Geraerts-Keeris, G.3
Broekhuizen, R.4
Rutten-van Mölken, M.5
Schols, A.6
-
12
-
-
69249123772
-
Current status of research on osteoporosis in COPD: A systematic review
-
Graat-Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009;34:209-218.
-
(2009)
Eur Respir J
, vol.34
, pp. 209-218
-
-
Graat-Verboom, L.1
Wouters, E.F.2
Smeenk, F.W.3
Van Den Borne, B.E.4
Lunde, R.5
Spruit, M.A.6
-
13
-
-
33644623093
-
Randomized controlled trial of alendronate in airways disease and low bone mineral density
-
Smith BJ, Laslett LL, Pile KD, Phillips PJ, Phillipov G, Evans SM, Esterman AJ, Berry JG. Randomized controlled trial of alendronate in airways disease and low bone mineral density. Chron Respir Dis 2004;1:131-137.
-
(2004)
Chron Respir Dis
, vol.1
, pp. 131-137
-
-
Smith, B.J.1
Laslett, L.L.2
Pile, K.D.3
Phillips, P.J.4
Phillipov, G.5
Evans, S.M.6
Esterman, A.J.7
Berry, J.G.8
-
14
-
-
65249174542
-
Vitamin D beyond bones in chronic obstructive pulmonary disease: Time to act
-
Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med 2009;179:630-636.
-
(2009)
Am J Respir Crit Care Med
, vol.179
, pp. 630-636
-
-
Janssens, W.1
Lehouck, A.2
Carremans, C.3
Bouillon, R.4
Mathieu, C.5
Decramer, M.6
-
15
-
-
77949784497
-
Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene
-
JanssensW, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, Coolen J, Mathieu C, Decramer M, Lambrechts D. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010;65:215-220.
-
(2010)
Thorax
, vol.65
, pp. 215-220
-
-
Janssens, W.1
Bouillon, R.2
Claes, B.3
Carremans, C.4
Lehouck, A.5
Buysschaert, I.6
Coolen, J.7
Mathieu, C.8
Decramer, M.9
Lambrechts, D.10
-
16
-
-
30344488982
-
Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey
-
DOI 10.1378/chest.128.6.3792
-
Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest 2005;128:3792-3798. (Pubitemid 43062638)
-
(2005)
Chest
, vol.128
, Issue.6
, pp. 3792-3798
-
-
Black, P.N.1
Scragg, R.2
-
17
-
-
0032552240
-
Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
-
DOI 10.1056/NEJM199808203390801
-
Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-497. (Pubitemid 28384881)
-
(1998)
New England Journal of Medicine
, vol.339
, Issue.8
, pp. 489-497
-
-
Gottlieb, S.S.1
McCarter, R.J.2
Vogel, R.A.3
-
18
-
-
52749097999
-
Impact ofcardioselective β-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis
-
van Gestel YR, Hoeks SE, Sin DD, Welten GM, Schouten O, Witteveen HJ, Simsek C, Stam H, Mertens FW, Bax JJ, et al. Impact ofcardioselective β-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med 2008;178:695-700.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 695-700
-
-
Van Gestel, Y.R.1
Hoeks, S.E.2
Sin, D.D.3
Welten, G.M.4
Schouten, O.5
Witteveen, H.J.6
Simsek, C.7
Stam, H.8
Mertens, F.W.9
Bax, J.J.10
-
19
-
-
77952694203
-
A curious case of beta-blockers in chronic obstructive pulmonary disease
-
Sin DD, Man SF. A curious case of beta-blockers in chronic obstructive pulmonary disease. Arch Intern Med 2010;170:849-850.
-
(2010)
Arch Intern Med
, vol.170
, pp. 849-850
-
-
Sin, D.D.1
Man, S.F.2
-
20
-
-
77950881229
-
Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: A randomized crossover trial
-
Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. J Am Coll Cardiol 2010;55:1780-1787.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1780-1787
-
-
Jabbour, A.1
Macdonald, P.S.2
Keogh, A.M.3
Kotlyar, E.4
Mellemkjaer, S.5
Coleman, C.F.6
Elsik, M.7
Krum, H.8
Hayward, C.S.9
-
21
-
-
41849085549
-
Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
-
DOI 10.1136/thx.2007.081893
-
Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008;63:301-305. (Pubitemid 351497940)
-
(2008)
Thorax
, vol.63
, Issue.4
, pp. 301-305
-
-
Dransfield, M.T.1
Rowe, S.M.2
Johnson, J.E.3
Bailey, W.C.4
Gerald, L.B.5
-
22
-
-
73449091199
-
Pharmacological actions of statins: Potential utility in COPD
-
Young RP, Hopkins R, Eaton TE. Pharmacological actions of statins: potential utility in COPD. Eur Respir Rev 2009;18:222-232.
-
(2009)
Eur Respir Rev
, vol.18
, pp. 222-232
-
-
Young, R.P.1
Hopkins, R.2
Eaton, T.E.3
-
23
-
-
68349104141
-
Associations between statins and COPD: A systematic review
-
Dobler CC, Wong KK, Marks GB. Associations between statins and COPD: a systematic review. BMC Pulm Med 2009;9:32.
-
(2009)
BMC Pulm Med
, vol.9
, pp. 32
-
-
Dobler, C.C.1
Wong, K.K.2
Marks, G.B.3
-
24
-
-
33744994082
-
Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease
-
DOI 10.1016/j.jacc.2006.04.039, PII S0735109706011077
-
Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006;47:2554-2560. (Pubitemid 43866389)
-
(2006)
Journal of the American College of Cardiology
, vol.47
, Issue.12
, pp. 2554-2560
-
-
Mancini, G.B.J.1
Etminan, M.2
Zhang, B.3
Levesque, L.E.4
FitzGerald, J.M.5
Brophy, J.M.6
-
25
-
-
46349098873
-
Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease
-
van Gestel YR, Hoeks SE, Sin DD, Simsek C, Welten GM, Schouten O, Stam H, Mertens FW, van Domburg RT, Poldermans D. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease. Am J Cardiol 2008;102: 192-196.
-
(2008)
Am J Cardiol
, vol.102
, pp. 192-196
-
-
Van Gestel, Y.R.1
Hoeks, S.E.2
Sin, D.D.3
Simsek, C.4
Welten, G.M.5
Schouten, O.6
Stam, H.7
Mertens, F.W.8
Van Domburg, R.T.9
Poldermans, D.10
-
26
-
-
38849125493
-
Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin
-
Lee TM, Lin MS, Chang NC. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol 2008;101:530-535.
-
(2008)
Am J Cardiol
, vol.101
, pp. 530-535
-
-
Lee, T.M.1
Lin, M.S.2
Chang, N.C.3
-
28
-
-
41749120109
-
Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: A cross-sectional study
-
DOI 10.1164/rccm.200707-1011OC
-
Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008;177:743-751. (Pubitemid 351490561)
-
(2008)
American Journal of Respiratory and Critical Care Medicine
, vol.177
, Issue.7
, pp. 743-751
-
-
Watz, H.1
Waschki, B.2
Boehme, C.3
Claussen, M.4
Meyer, T.5
Magnussen, H.6
-
29
-
-
70350088412
-
The metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity
-
Watz H, Waschki B, Kirsten A, Müller KC, Kretschmar G, eyer T, Holz O, Magnussen H. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009;136:1039-1046.
-
(2009)
Chest
, vol.136
, pp. 1039-1046
-
-
Watz, H.1
Waschki, B.2
Kirsten, A.3
Müller, K.C.4
Kretschmar, G.5
Eyer, T.6
Holz, O.7
Magnussen, H.8
-
30
-
-
47949104798
-
The role of exercise and PGC1alpha in inflammation and chronic disease
-
Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008;454:463-469.
-
(2008)
Nature
, vol.454
, pp. 463-469
-
-
Handschin, C.1
Spiegelman, B.M.2
-
32
-
-
77953255795
-
Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease
-
Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G, Decramer M, Gosselink R. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:1072-1077.
-
(2010)
Am J Respir Crit Care Med
, vol.181
, pp. 1072-1077
-
-
Troosters, T.1
Probst, V.S.2
Crul, T.3
Pitta, F.4
Gayan-Ramirez, G.5
Decramer, M.6
Gosselink, R.7
-
33
-
-
55949119252
-
Muscle as an endocrine organ: Focus on muscle-derived interleukin-6
-
Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008;88:1379-1406.
-
(2008)
Physiol Rev
, vol.88
, pp. 1379-1406
-
-
Pedersen, B.K.1
Febbraio, M.A.2
-
34
-
-
13444250953
-
The effects of a smoking cessation intervention on 14.5-year mortality: A randomized clinical trial
-
Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233-239. (Pubitemid 40216240)
-
(2005)
Annals of Internal Medicine
, vol.142
, Issue.4
, pp. 233-239
-
-
Anthonisen, N.R.1
Skeans, M.A.2
Wise, R.A.3
Manfreda, J.4
Kanner, R.E.5
Connett, J.E.6
|